Duncan Gallagher serves as Executive at Health Catalyst, Inc., where they oversee executive responsibilities. Since joining the company, Duncan Gallagher has executed 13 insider transactions totaling $175.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 17, 2026 involved receiving (via award) 7,562 shares valued at $0.
Duncan Gallagher currently holds 132,023 shares of Health Catalyst, Inc. (HCAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Duncan Gallagher has been a net buyer of HCAT stock. They have purchased $175.0K and sold $0 worth of shares.
Duncan Gallagher's most recent insider trade was on Feb 17, 2026, when they sold 7,562 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 1, 2025 | HCAT | $0 | Award | 4,970 | $N/A | Discretionary |
| Jul 9, 2025 | HCAT | $0 | Award | 36,231 | $N/A | Discretionary |
| Sep 1, 2024 | HCAT | $0 | Award | 2,414 | $N/A | Discretionary |
| Jun 13, 2024 | HCAT | $0 | Award | 20,807 | $N/A | Discretionary |
| Jun 14, 2023 | HCAT | $0 | Award | 12,505 | $N/A | Discretionary |
| Jun 14, 2023 | HCAT | $0 | Award | 5,806 | $N/A | Discretionary |
| Aug 19, 2022 | HCAT | $76.8K | Purchase | 6,600 | $11.63 | Discretionary |
| Aug 18, 2022 | HCAT | $98.2K | Purchase | 8,400 | $11.69 | Discretionary |
| Jun 14, 2022 | HCAT | $0 | Award | 11,677 | $N/A | Discretionary |
| Jun 10, 2021 | HCAT | $0 | Award | 3,285 | $N/A | Discretionary |
| Jun 12, 2020 | HCAT | $0 | Award | 5,443 | $N/A | Discretionary |